NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Specialty Chemicals · USD

ASP Isotopes Inc. (ASPI) Stock Analysis

ASP Isotopes Inc. (ASPI) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.

ASPI

$4.20

+$0.30 (+7.69%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ASPI with… →

ASPI Key Statistics

As of Sep 4, 2026
Trading
Open
$3.95
Previous Close
$3.90
Day's Range
3.91–4.27
52-Week Range
3.51–14.49
Volume
3.83M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
3.60
Valuation
Market Cap
$643.90M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
20.87
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.55
Financials (FY)
Revenue (FY)
$23.85M+475.51%
Net Income (FY)
−$175.09M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
153.31M
1-Year Return
−47.24%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
4.01M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ASPI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−21.50%
2025+18.10%
2024+153.07%
2023+13.29%
2022 (partial year)−40.82%

As of September 4, 2026.

ASPI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$23.85M−$175.09M−734.2%
2024$4.14M−$32.33M−780.3%
2023$433.03K−$16.29M−3761.0%
2022$0.00−$4.95M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$23.85M$3.41M−$57.19M−$175.09M−734.2%
2024$4.14M$1.60M−$26.35M−$32.33M−780.3%
2023$433.03K$138.97K−$16.04M−$16.29M−3761.0%
2022$0.00$0.00−$5.10M−$4.95M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ASPI Valuation vs Specialty Chemicals Median

Median of 71 stocks
MetricASPISpecialty Chemicals medianvs median
P/S ratio20.871.6812.4x the median
Profit margin0.00%0.08%0.1 pts below

Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values ASP Isotopes Inc. (ASPI) at $643.90M. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. The company reports 271 employees.

ASPI last closed at $4.20 on September 4, 2026. That is +$0.30 (+7.69%) against the previous close. The 52-week range on file runs from $3.51 to $14.49. The latest close sits 19.66% above that 52-week low.

Financial Health

In fiscal 2025, ASP Isotopes Inc. reported revenue of $23.85M. Against the prior fiscal year total of $4.14M, that is a change of +475.51%. The same year closed with a net loss of $175.09M. The reported profit margin is 0%. That is 0.1 percentage points below the Specialty Chemicals median of 0.08%. Earnings per share on a trailing basis come to −1.55.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $23.85M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 20.87. On price-to-sales that is 12.4 times the Specialty Chemicals median of 1.68. 71 Specialty Chemicals companies report these metrics, and the medians quoted come from that group.

The reported beta is 3.6. Daily returns over the trailing 3 years annualize to a volatility of 107.49%. Over the trailing twelve months the price has returned −47.24%. Measured over 3 years, that is +53.12% a year compounded.

Growth & Income

The record shows no dividend for ASPI.

The strongest complete calendar year on file is 2024 at +153.07%; the weakest is 2023 at +13.29%. Of the 3 complete calendar years on file, 3 finished higher. So far in 2026 the price is −21.50%.

Peer Comparison

ASP Isotopes Inc. (ASPI) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
ASP Isotopes Inc. ASPI $643.90M —
Linde plc LIN $220.15B 30.9
The Sherwin-Williams Company SHW $81.01B 30.8
Ecolab Inc. ECL $78.29B 37.4

The Specialty Chemicals industry average P/E ratio is 28.7x. ASP Isotopes Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Specialty Chemicals Stocks

LIN

Linde plc

$220.15B

 SHW

The Sherwin-Williams Company

$81.01B

 ECL

Ecolab Inc.

$78.29B

 APD

Air Products and Chemicals, Inc.

$67.09B

 PPG

PPG Industries, Inc.

$25.02B

 IFF

International Flavors & Fragrances Inc.

$22.03B
View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

BHP

BHP Group Limited

$229.80B

 RIO

Rio Tinto Group

$167.95B

 SCCO

Southern Copper Corporation

$167.82B

 NEM

Newmont Corporation

$134.97B

 FCX

Freeport-McMoRan Inc.

$104.44B
View all Basic Materials stocks →

About ASP Isotopes Inc.

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Visit website →